Spyre Therapeutics, Inc.

NASDAQ (USD): Spyre Therapeutics, Inc. (SYRE)

Last Price

24.35

Today's Change

+0.50 (2.09%)

Day's Change

23.66 - 24.83

Trading Volume

207,119

Overview

Market Cap

1 Billion

Shares Outstanding

58 Million

Avg Volume

534,420

Avg Price (50 Days)

29.13

Avg Price (200 Days)

30.59

PE Ratio

-0.64

EPS

-37.90

Earnings Announcement

26-Feb-2025

Previous Close

23.85

Open

23.66

Day's Range

23.66 - 24.83

Year Range

20.07 - 47.97

Trading Volume

214,122

Price Change Highlight

1 Day Change

2.10%

5 Day Change

4.28%

1 Month Change

-13.00%

3 Month Change

-16.47%

6 Month Change

-4.47%

Ytd Change

2.10%

1 Year Change

8.03%

3 Year Change

-78.06%

5 Year Change

-87.20%

10 Year Change

-90.03%

Max Change

-90.03%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. The company's pipeline includes extended half-life antibodies targeting a4ß7, TL1A, and IL-23. The company was formerly known as Aeglea BioTherapeutics, Inc. and changed its name to Spyre Therapeutics, Inc. in November 2023. Spyre Therapeutics, Inc. was founded in 2013 and is based in Waltham, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment